pd 142893 has been researched along with irl 1620 in 2 studies
| Studies (pd 142893) | Trials (pd 142893) | Recent Studies (post-2010) (pd 142893) | Studies (irl 1620) | Trials (irl 1620) | Recent Studies (post-2010) (irl 1620) |
|---|---|---|---|---|---|
| 64 | 0 | 3 | 257 | 2 | 27 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiou, WJ; Magnuson, SR; Opgenorth, TJ; Wu-Wong, JR | 1 |
| Chiou, WJ; Dixon, D; Magnuson, SR; Opgenorth, TJ; Sundy, S; Wu-Wong, JR | 1 |
2 other study(ies) available for pd 142893 and irl 1620
| Article | Year |
|---|---|
Endothelin receptor agonists and antagonists exhibit different dissociation characteristics.
Topics: Amino Acid Sequence; Animals; Binding, Competitive; Brain Chemistry; CHO Cells; Cricetinae; Endothelin Receptor Antagonists; Endothelins; Molecular Sequence Data; Oligopeptides; Peptide Fragments; Pyrimidines; Receptors, Endothelin; Sulfonamides; Swine | 1994 |
Dissociation characteristics of endothelin receptor agonists and antagonists in cloned human type-B endothelin receptor.
Topics: Animals; CHO Cells; Cricetinae; Endothelin Receptor Antagonists; Endothelins; Humans; Kinetics; Molecular Weight; Oligopeptides; Peptide Fragments; Protein Binding; Pyrimidines; Receptor, Endothelin B; Receptors, Endothelin; Recombinant Fusion Proteins; Sulfonamides | 1997 |